NCT06880653 Dose Response of Exercise for Arthritis Management
| NCT ID | NCT06880653 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of South Carolina |
| Condition | Arthritis |
| Study Type | INTERVENTIONAL |
| Enrollment | 285 participants |
| Start Date | 2025-03-28 |
| Primary Completion | 2028-10-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 285 participants in total. It began in 2025-03-28 with a primary completion date of 2028-10-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of the study is to see examine the effects of 3 different levels of physical activity (45 minutes/week, 90 minutes/week, or 150 minutes/week) on arthritis symptoms.
Eligibility Criteria
Inclusion Criteria: * 18 years or older * Have a doctor diagnosed form of arthritis, rheumatoid arthritis, gout, lupus, or fibromyalgia * Ability to read and write in English Exclusion Criteria: * Have any contraindications to exercise (besides arthritis) * Engage in \>45 min/week of Actigraph assessed moderate to vigorous intensity activity * Are pregnant, breastfeeding, or planning to become pregnant in the next year * Are planning to relocate out of the Columbia, SC area in the next 12 months, * Do not have a device compatible with Fitbit * Have uncontrolled hypertension (e.g., systolic blood pressure \> 160 mmHg or diastolic blood pressure \> 100 mmHg) * Plan to have a surgery that affects mobility in the next 12 months * Have a serious cognitive impairment. * Not willing to be randomized to any of the 3 conditions, do not believe they could adhere to the goals, or do not believe they could achieve the highest dose of activity (150 minutes/week).
Contact & Investigator
Christine Pellegrini, PhD
PRINCIPAL INVESTIGATOR
University of South Carolina
Frequently Asked Questions
Who can join the NCT06880653 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Arthritis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06880653 currently recruiting?
Yes, NCT06880653 is actively recruiting participants. Contact the research team at EWINGARD@mailbox.sc.edu for enrollment information.
Where is the NCT06880653 trial being conducted?
This trial is being conducted at Columbia, United States.
Who is sponsoring the NCT06880653 clinical trial?
NCT06880653 is sponsored by University of South Carolina. The principal investigator is Christine Pellegrini, PhD at University of South Carolina. The trial plans to enroll 285 participants.